2 ASX shares to buy now at bargain prices that you've forgotten about

There are many cheap stocks currently out there to consider. Here's a pair you might not have on your radar.

| More on:
A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wise long-term investors will have been using this year's depressed market to snap up some bargains.

However, when the whole market is so down in the dumps, you can't possibly keep track of all the cheapies out there.

That's why it's worth listening to some experts who have spotted some excellent candidates:

18% share price upside while interest rates head up

With interest rates looking very likely to rise this year, finance and insurance ASX shares have already been tipped by many analysts as value plays.

But one name that hasn't popped up too much is Challenger Ltd (ASX: CGF).

The annuities and income funds provider is a buy in Morgans investment advisor Jabin Hallihan's book at the moment.

"A key feature of these products is they distribute cash flow and protect against market movements and inflation risks," he told The Bull.

"Such products appeal for their stability, particularly during times of market volatility."

The stock could potentially be at an attractive entry point right now, having fallen more than 4% this year so far.

Hallihan's team has a 12-month price target of $7.74, which is an 18% upside.

Challenger shares also return a handy dividend yield of around 3.35%.

Australians need healthcare, regardless of what else is happening

Healthcare is one of those sectors that is somewhat resistant to economic and interest rate cycles. People will always need to take care of their health.

As such, Wilsons investment advisor Peter Moran would currently buy shares in Integral Diagnostics Ltd (ASX: IDX).

"This diagnostic imaging services company recently undertook a $90 million capital raising to fund the acquisition of Peloton Radiology."

The Integral share price has fallen close to 23% so far this year.

Moran admitted February financials were not favourable, but expected the underperformance to be temporary.

"First half 2022 operating net profit after tax was down 21.7% on the prior corresponding period," he said.

"The result was impacted by COVID-19 restrictions. However, with restrictions easing, we expect profitability to recover as margins improve and recent investments in their business start to produce a return."

Moran's team holds an overweight recommendation on Integral shares.

The stock is somewhat polarising, with CMC Markets showing 6 of 13 analysts rating it as a strong buy while 5 label it as a hold.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger Limited and Integral Diagnostics Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A bricklayer peeps over the top of a brick wall he is laying with a level measuring tool on top.
Broker Notes

Are Brickworks shares a buy, hold or sell ahead of earnings season?

Brokers have been weighing property gains, US headwinds, and merger impacts to form a view.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy these 2 ASX consumer stocks in the dip: expert

Can you guess which 2 were named?

Read more »

Miner puts thumbs up in front of gold mine quarry
Gold

Why Macquarie expects this ASX 200 gold stock to surge 55%

Macquarie forecasts a big rebound ahead for this beaten down ASX 200 gold miner.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

4 ASX shares to buy this week: experts

Looking for investment inspiration?

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Macquarie forecasts 28% upside for this ASX All Ords stock

Let's see why the broker is feeling bullish about this name.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Broker Notes

What's Macquarie focused on this earnings season?

Here's what the broker is saying about next month's results releases.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Should you buy Zip shares and sell NextDC shares?

Let's see what one analyst is saying about these popular shares.

Read more »